Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sembiosys Genetics Inc. SBIYF

"SemBioSys Genetics Inc is engaged in developing high-value proteins and oils in plant seeds using its unique proprietary genetic expression and manufacturing technology platforms. The Company has operations in United States and Canada."


GREY:SBIYF - Post by User

Post by CurlyMickon Apr 18, 2012 11:49am
340 Views
Post# 19807692

Last Contact

Last Contact

From ASC this morning.....I will try to follow up tomorrow...but anyone else that can please do too.

Thank you for your e-mail to the Alberta Securities Commission (ASC) regarding Sembiosys Genetics Inc.
The ASC is responsible for administering Alberta securities laws, including investigating, prosecuting and sanctioning breaches. Under section 45 of the Alberta Securities Act (ASA), ASC complaints and investigations are confidential until brought to the point of a hearing or enforcement action, at which time, all relevant evidence must be disclosed to respondents, complainants may be called as witnesses, and certain details are posted at the ASC web site at https://www.albertasecurities.com. While we will take reasonable steps to ensure confidentiality and protect the identity of complainants, during the course of an investigation, the identity of complainants may become obvious to suspects.
The contact information for Sembiosys is 403-250-5424 ; Ross Marshall SR. VP, 416-815-0700 ext 238, e-mail rmarshall@equicomgroup.com ; or Rick Pierce President US & International Operations, 617-447-8299 , e-mail piercer@sembiosys.com. Alternatively you may wish to contact Sembiosys Transfer Agent ComputerShare Trust Company of Canada or Lawyer McCarthy Tétrault LLP.
Regards,
Dolores Ivany-Fagan
Assessment Officer
<< Previous
Bullboard Posts
Next >>